Acute lung injury timely associated with the administration of tocilizumab

Reumatismo 2026 Open access

Read full text
Authors: Alojzija Hočevar, Anja Menard Srpčič, Katja Lakota, Miša Fister
DOI: 10.4081/reumatismo.2026.1947
Cited by: 1
References: 4

Abstract

Dear editor, The interleukin-6 receptor inhibitor tocilizumab has been successfully used to treat various autoimmune diseases and has an acceptable, well-established safety profile...

Fields of Study & Subjects

Rheumatoid Arthritis Research and Therapies Cancer Immunotherapy and Biomarkers Urticaria and Related Conditions

Publication details

Journal / source
Reumatismo
Publisher
PAGEPress Publications
Volume
78
Issue
1
Publication date
29 January 2026
Language
EN